Aspen Pharmacare's share price surges after R27 billion APAC business sale

Aspen Pharmacare Holdings has successfully completed the sale of its Asia Pacific business for R27 billion, resulting in a significant increase in its share price. This strategic move aims to strengthen the company's balance sheet and enhance financial flexibility.

Raccontata daiol.co.za